Ocugen Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 64.51. In total, the insiders bought 11 482 912 and sold 2 371 575 OCGN shares in the last 100 trades.

Insider Power

(Last 100 transactions)
64.51
Buy 11 482 912 Shares
Sell 2 371 575 Shares

Historical Insider Trades

Date Type Action Person Amount
Apr 16, 2024 Option (Right to Buy) Buy Qamar Huma 308 465
Mar 18, 2024 Common Stock Buy Qamar Huma 0
Jan 03, 2024 Common Stock Sell Musunuri Shankar 180 204
Jan 03, 2024 Common Stock Sell Upadhyay Arun 41 633
Jan 02, 2024 Option (Right to Buy) Buy Musunuri Shankar 492 126
Jan 02, 2024 Option (Right to Buy) Buy Upadhyay Arun 137 795
Sep 16, 2023 Common Stock Sell Upadhyay Arun 842
Sep 15, 2023 Buy Breininger Michael 0
Jun 16, 2023 Common Stock Sell Upadhyay Arun 917
Jun 14, 2023 Common Stock Buy Zhang Junge 200 278
Jun 09, 2023 Option (Right to Buy) Buy Castillo Kirsten 112 205
Jun 09, 2023 Option (Right to Buy) Buy Fernandes Prabhavathi 112 205
Jun 09, 2023 Option (Right to Buy) Buy Kompella Uday 112 205
Jun 09, 2023 Option (Right to Buy) Buy Kumar Ramesh 112 205
Jun 09, 2023 Option (Right to Buy) Buy Whittington Marna C 112 205
Jun 09, 2023 Option (Right to Buy) Buy Zhang Junge 112 205
Mar 06, 2023 Common Stock Buy Vu Quan Anh 0
Mar 06, 2023 Option (Right to Buy) Buy Vu Quan Anh 196 850
Feb 16, 2023 Common Stock Buy Musunuri Shankar 100 000
Feb 16, 2023 Common Stock Sell Musunuri Shankar 100 000
Feb 16, 2023 Option (Right to Buy) Sell Musunuri Shankar 100 000
Jan 17, 2023 Common Stock Buy Musunuri Shankar 100 000
Jan 17, 2023 Common Stock Sell Musunuri Shankar 100 000
Jan 17, 2023 Option (Right to Buy) Sell Musunuri Shankar 100 000
Jan 03, 2023 Common Stock Sell Upadhyay Arun 7 102
Click to get the best stock tips daily for free!

About Ocugen Inc

Ocugen Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related ... OCGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT